BACKGROUND: Alcohol use disorders (AUDs) are highly prevalent and associated with non-
adherence to antiretroviral therapy, decreased health care utilization and poor HIV treatment …

Relapse is common in substance use disorders (SUDs), even among treated individuals.
The goal of this article was to systematically review the existing evidence on mindfulness …

ContextAlcohol dependence treatment may include medications, behavioral therapies, or
both. It is unknown how combining these treatments may impact their effectiveness …

Context Alcoholism is a chronic, relapsing illness in which stress and alcohol cues
contribute significantly to relapse risk. Dysregulation of the hypothalamic-pituitary-adrenal …

Objective: Although recovery increasingly guides substance use disorder services and
policy, definitions of recovery continue to lack specificity, thereby hindering measure …

OBJECTIVE: To update clinicians on the latest in evidence-based treatments for substance
use disorders (SUD) and non-substance use disorders among adults and suggest how …

Background: Recent clinical trials and case‐reports indicate that baclofen, a GABAB agonist,
may have efficacy for alcohol dependence. Baclofen has been shown to enhance …

Context Naltrexone hydrochloride treatment for alcohol dependence works for some
individuals but not for everyone. Asn40Asp, a functional polymorphism of the μ-opioid …

Alcoholic liver disease (ALD) is a global healthcare problem and socioeconomic issue that
is primarily driven by chronic and/or excessive alcohol consumption. Upon alcohol …

Objective: Alcoholism is associated with gray matter volume deficits in frontal and other brain
regions. Whether persistent brain volume deficits in abstinence are predictive of subsequent …